16:15 EST Aprea Therapeutics (APRE) files to sell 5.5M shares of common stock for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APRE:
- Advancing APR-1051 in HPV-Positive Cancers and Extended Cash Runway Underpin Aprea Therapeutics Buy Rating and $5 Target
- Aprea Therapeutics price target lowered to $5 from $20 at H.C. Wainwright
- Aprea Therapeutics CEO issues letter to shareholders
- Aprea Therapeutics Secures $3.1M in Private Placement
- Aprea Therapeutics prices 2.62M shares at $1.165 in private placement